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Introduction
Willebrand factor (vWF) and form clots. Patients often Bernard-Soulier syndrome (BSS) is a rare, inheritable report spontaneous epistaxis, bleeding gums or heavy (autosomal recessive) platelet disorder affecting an estimated menstrual periods. BSS patients require rigorous 1 in every 1 million individuals [1, 2] . Patients with BSS are at perioperative planning [2] , however, the literature is devoid risk of severe bleeding. A mutation involving glycoprotein of reports describing BSS patients undergoing orthopaedic complex 1b-V-IX renders platelets unable to bind Von www.jocr.co.in surgery. We present a young female patient with BSS that lateral decubitus position, supported by a Stulberg frame underwent total hip arthroplasty (THA) for her dysplastic (Innomed Inc., Savannah, GA, USA). A Hardinge approach left hip.
was used to the left hip. Meticulous haemostasis was maintained using cautery throughout the case. Particular attention was taken to avoid undue tension through soft A 40 year old, 83Kg female with developmental dysplasia of tissues during dislocation of the hip. Similarly, bone bleeding her left hip (DDH) was referred to us for consideration of left following transection of the femoral neck and reaming of the THA having suffered increasing left hip pain over the past acetabulum and femoral canal was addressed immediately. three years. Her diagnosis of DDH was not made until Gauze soaked in tranexamic acid (Pfizer Inc., NY, USA, 2g in adulthood despite her left leg being shorter than her right 10 mL sterile normal saline) was packed into the femoral leg by 2.5 cm. She was diagnosed with BSS at the age of 18, canal and acetabulum for a period of 3-4 minutes prior to and her haematology reports confirm 2 prior hospital placement of implants. admissions related to delayed bleeding following wisdom-The femoral component (Accolade II; Stryker Canada, teeth extraction at the age of 20 and cervical cone biopsy; the Hamilton, ON, CA) was impacted into the femoral canal in the latter of which required transfusion with platelets and typical fashion. To optimize functional range, we used an packed red blood cells (pRBC). Prior to this, she had been anatomic dual mobility (ADM®), bearing hip system from taking birth control pills from the age 14 for heavy Stryker (Fig 1) . Bleeding was minimal following impaction of menstruation.
either the femoral or acetabular prostheses. Muscle and Pre-operative cross-match and group and screen of blood was surrounding fascial layers were infiltrated with 0.5% conducted confirming blood type A+. Blood work also Marcaine/epinephrine (1:1000; 40 mL). The incision was confirmed that she was not Factor XIII deficit as initially meticulously closed in multiple layers followed by sterisuspected (FXIII activity, 1.04 U/mL). Her glycoprotein 1b strips™ and mepore® dressings. level was 15% with an estimated platelet count of 12 Systolic blood pressure was maintained below 125 mmHg (x109/L) and INR 0.9. Her euglobulin lysis time was also throughout the surgery. Total operative time was 85 minutes. well within acceptable limits (4.5 h). We consulted our Estimated blood loss was 450 mL. Patient received a 1L bolus Thrombosis, Haemophilia and Internal Medicine teams for pre-operative optimization. Having a Clinical Nurse Specialist coordinate the patient care path was fundamental to this process. Tranexamic acid (TA) 1g po TID was initiated 24 hours prior to surgery and continued until 14 days post-operatively. 20 mcg of DDAVP (desmopressin) diluted into 50 mL of normal saline was given intravenously over a period of 30 minutes, 1 hour prior to surgery. Immediately following this, she received 1 adult dose (4 units/318 mL) of pooled, buffy-coat platelets which elevated her platelets to 79 (x109/L) along with 1 unit of pRBC to bring her haemoglobin (Hb) to 135 (Table 1) . Intravenous antibiotics (Ancef, 2g) were given within 30 minutes of surgery. Arterial lines and additional peripheral lines were avoided to limit potential bleeding. Induction of general anaesthesia was conducted using a mixture of intravenous propofol (170 mg), sufentanil (20 mcg), versed (2 mg) and rocuronium (50 mcg). A glideScope® (Verathon Inc., Bothell, WA, USA) was used for placement of the endotracheal tube. Anaesthesia maintenance comprised isoflurane (1.8%) with 58% O2 at 1.2L/min and air at 1.3L/min. Once sedate, our patient was positioned in a standard right
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Bisland SK et al membrane-bound glycoprotein 1b/V/IX found on platelets have been described to explain this phenomenon. Transfusions of allogeneic platelets remain the definitive treatment for patients with BSS although intravenous injection of recombinant activated Factor VII (rFVIIa) is also effective [1, 4] . The potential for developing anti-platelet antibodies with repeat platelet transfusions remains true although Mansour et al suggest that this risk may be lessened for patients with BSS since the 1b/V/IX complex is not associated with a platelet-specific antigen site [1, 2, 13] . Total hip arthroplasty is a major surgery with significant risks of blood loss, deep vein thromboembolism (DVT), pulmonary embolism (PE) and infection. Estimates of blood loss following THA in patient without a bleeding disorder vary considerably within the literature; from 300-1500 mL with 20-30% risk of DVT or PE [5] [6] [7] . Tranexamic acid (TA) is an anti-fribinolytic that inhibits the activation of plasminogen to plasmin with an of normal saline intra-operatively. Her vitals remained established role in joint arthroplasty and good evidence to stable throughout the surgery.
support reduced blood loss with no increased risk of DVT or Post-operatively, daily transfusions of platelets were given up PE [8, 9] . Protocols for TA use, however, vary considerably to post-operative day (POD) 14. Transfusions comprised 2 with no formal guidelines [10] . Doses range from 10-15 single donor (232 mL), 4 plateletpharesis (208 ±44 mL) and mg/Kg for intravenous or oral administration. We provided 8 pooled, buffy coated platelets (345 ±15mL). Minor cross-oral TA peri-operatively and topical TA through the open match check was conducted daily. Platelet counts dropped wound intra-operatively with doses equivalent to 12 mg/Kg by 40% post-operatively but recovered by POD 6 (see Table po TID and 24 mg/kg respectively. A prospective randomized 1). DDAVP (20 mcg, subcutaneous) was continued daily control trial using topical TA (2g/100 mL 0.9% saline) is until POD 4. Serum sodium levels remained stable; the described; the results of which are pending [11] . lowest reading was 128 mmol/L on POD 2, recovering to DDAVP use in bleeding disorders is well reported [1, 12] . 136 mmol/L by POD 6. Systolic blood pressures were also DDAVP binds V2 receptors found on endothelial cells to stable at 103 ±14 mmHg, the lowest (98/59) occurring POD increase vWF release and promote Factor VIII. DDAVP also 1. Her blood work was recorded daily, a summary of which stimulates renal reabsorption of water, which theoretically is shown in Table 1 . She was weight bearing as tolerated could cause hyponatraemia [12] . We saw a slight drop over from POD 1. Daily dressing checks confirmed no bleeding the peri-operative period, however values quickly corrected concerns at the incision site. DVT prophylaxis comprised after the DDAVP was stopped. moonboots starting POD 0. Her pain was controlled Anaesthesia remains challenging in these patients [1, 2] . effectively with oral hydromorphone contin (6mg, BID) Halothane is known to inhibit platelet function, while and Tylenol (975 mg, q4h). Patient entered into isoflurane and enflurane do not [13] . Importantly, the rehabilitation POD 7 and was discharged home on POD 19 inhibitory effect of propofol on platelets is not evident at following complete review by our Haematology and clinically relevant doses and its ease of induction outweighs medicine teams.
this theoretical risk [14] . Epidural or lumbar spine blocks The overall leg length discrepancy was improved from 2.5 and/or controlled hypotension can also reduce potential cm to 1 cm without the need for additional soft tissue release. blood loss by 30-50% [15] . Nevertheless, the potential risk for bleeding in and around the spinal cord cannot not be ignored. We strived for a systolic blood pressure of 100 mmHg intraBernard-Soulier Syndrome, first described in 1948, is an operatively and our total intra-operative blood loss was inheritable bleeding disorder affecting 1:1,000,000 comparable to what we expect in patients without BSS. individuals [1] [2] [3] . Patients have prolonged bleeding times Furthermore, we only used 1L of 0.9% saline intra-operatively and are at high risk for spontaneous bleeding with the so avoided haemodilution which could potentially exacerbate potential for death. A number of mutations affecting the our existing coagulopathy.
Discussion
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We experienced no adverse transfusions reactions despite multiple platelet transfusions post-operatively and Hb remained stable. We avoided use of non-steroidal anti-inflammatories which are known to increase peri-operative blood loss following THA. Similarly, conservative use of narcotics is warranted to avoid extreme hypotensive episodes. We found long acting hydromorphone with extra-strength Tylenol to be most effective for pain control allowing the patient to mobilize quickly after surgery. We made no special concessions regarding the patient's DDH other than use of the ADM implant and minimal acetabular reaming. This is the first report of a successful THA on a young adult with Bernard-Soulier syndrome. Pre-operative planning is imperative with strong communication between consulting teams. Strict intra-operative haemostasis with limited soft tissue perturbation, limited reaming of the acetabulum and tight, multi-layered closure are instrumental to limit blood loss. The utility of anti-fibrinolytics and DDAVP in BSS patients is clearly borne out in this study.
Conclusion
